Explore

TrendlineTrendline
Tonix Pharmaceuticals Anticipates Q3 2026 Financial Results, Analysts Project Loss Amid Revenue Growth

Tonix Pharmaceuticals Anticipates Q3 2026 Financial Results, Analysts Project Loss Amid Revenue Growth

Tonix Pharmaceuticals Anticipates Q3 2026 Financial Results, Analysts Project Loss Amid Revenue Growth
TrendlineTrendline
Veeva Systems Hosts Analyst/Investor Day, Outlines Future Strategies

Veeva Systems Hosts Analyst/Investor Day, Outlines Future Strategies

Veeva Systems Hosts Analyst/Investor Day, Outlines Future Strategies
TrendlineTrendline
Marathon Petroleum Stock Experiences Significant 5-Day Decline, Erasing Billions in Market Value

Marathon Petroleum Stock Experiences Significant 5-Day Decline, Erasing Billions in Market Value

Marathon Petroleum Stock Experiences Significant 5-Day Decline, Erasing Billions in Market Value
TrendlineTrendline
Moderna Reports 29% Revenue Growth to $1.3 Billion in Q3 2026, Raises Full-Year Guidance

Moderna Reports 29% Revenue Growth to $1.3 Billion in Q3 2026, Raises Full-Year Guidance

Moderna Reports 29% Revenue Growth to $1.3 Billion in Q3 2026, Raises Full-Year Guidance
TrendlineTrendline
Zai Lab Reports Third Quarter 2026 Financial Results and Pipeline Advancements

Zai Lab Reports Third Quarter 2026 Financial Results and Pipeline Advancements

Zai Lab Reports Third Quarter 2026 Financial Results and Pipeline Advancements
TrendlineTrendline
Moderna Reports Strong Q3 2026 Earnings, Raises Full-Year Guidance, and Advances Oncology Pipeline

Moderna Reports Strong Q3 2026 Earnings, Raises Full-Year Guidance, and Advances Oncology Pipeline

Moderna Reports Strong Q3 2026 Earnings, Raises Full-Year Guidance, and Advances Oncology Pipeline
TrendlineTrendline
Moderna Raises 2026 Outlook Amid Stronger Vaccine Sales and Cost Reductions

Moderna Raises 2026 Outlook Amid Stronger Vaccine Sales and Cost Reductions

Moderna Raises 2026 Outlook Amid Stronger Vaccine Sales and Cost Reductions
TrendlineTrendline
Lucid Group Stock Experiences Significant Decline Ahead of Earnings Report

Lucid Group Stock Experiences Significant Decline Ahead of Earnings Report

Lucid Group Stock Experiences Significant Decline Ahead of Earnings Report
TrendlineTrendline
Niagen Bioscience Reports Q3 2026 Financial Results Amidst Increased Competition and Strategic Investments

Niagen Bioscience Reports Q3 2026 Financial Results Amidst Increased Competition and Strategic Investments

Niagen Bioscience Reports Q3 2026 Financial Results Amidst Increased Competition and Strategic Investments
TrendlineTrendline
Macy's Stock Declines Amidst Broader Market Gains, Analysts Adjust Estimates

Macy's Stock Declines Amidst Broader Market Gains, Analysts Adjust Estimates

Macy's Stock Declines Amidst Broader Market Gains, Analysts Adjust Estimates
TrendlineTrendline
Moderna Reports Q3 2026 Profit, Signaling Shift from Consistent Losses

Moderna Reports Q3 2026 Profit, Signaling Shift from Consistent Losses

Moderna Reports Q3 2026 Profit, Signaling Shift from Consistent Losses
TrendlineTrendline
Planet Fitness Stock Jumps 4.3% Following Strong Q3 2026 Results and Strategic Initiatives

Planet Fitness Stock Jumps 4.3% Following Strong Q3 2026 Results and Strategic Initiatives

Planet Fitness Stock Jumps 4.3% Following Strong Q3 2026 Results and Strategic Initiatives